Cancer Genetics, Inc. CEO Panna Sharma to Participate in Panel at BioNJ CEO Summit

RUTHERFORD, N.J., Oct. 4, 2013 (GLOBE NEWSWIRE) -- Cancer Genetics, Inc. (Nasdaq:CGIX) ("CGI" or the "Company"), an emerging leader in DNA-based cancer diagnostics that personalizes the clinical management of difficult-to-diagnose cancers, today announced its president and CEO, Panna Sharma, will participate in a panel discussion at BioNJ's inaugural CEO Summit from 1:40 p.m. to 2:40 p.m. ET on October 4, 2013 in Bridgewater, New Jersey. The first of its kind summit will bring together chief executive officers and leaders from major biotech and pharmaceutical firms from New Jersey and beyond this fall to share their knowledge, experiences and views on the future in wide-ranging discussions with fellow executives, investors, entrepreneurs, academics and other members of the State's diverse and ever-evolving life sciences community.

Help employers find you! Check out all the jobs and post your resume.